Sort
51,593 grants matching “hepatitis”
In Situ Albumin Binding siRNAs for Triple Negative Breast Cancer Tumor Penetration and Molecularly Targeted Therapy
$553,948Craig Lewis Duvall · Vanderbilt University · R01 · FY2022 · CA
Genetic Approaches to Cholesterol Metabolism in Humans
$553,904Helen H. Hobbs · Ut Southwestern Medical Center · P01 · FY2010 · HL
Molecular Evolution Strategies to Derive New Recombinant AAV Vectors
$553,871Mark A Kay · Stanford University · R01 · FY2009 · HL
Epigenetic markers of severity in nonalcoholic fatty liver disease
$553,850Johanna K Distefano · Translational Genomics Research Inst · R01 · FY2020 · DK
Regulation of hepatic glucose fluxes
$553,838Meredith A Hawkins · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · DK
Exploring the Fetal Origins Hypothesis in Diverse Youth
$553,837Dana Dabelea · University Of Colorado Denver · R01 · FY2015 · DK
Preventing Bacterial and Viral Infections among Injection Drug Users
$553,820Michael D Stein · Boston University Medical Campus · R01 · FY2017 · DA
Metabolism and Toxicity Core
$553,754Timothy E O'Toole · University Of Louisville · P42 · FY2025 · ES
Low Dose Interleukin-2 for Regulatory T cell Modulation and the Treatment of CrohnâÂÂs Disease
$553,742Scott B Snapper · Boston Children'S Hospital · R01 · FY2021 · DK
Developing Methods for Precise, Safe and Target-location Specific Histotripsy of Liver Tumors
$553,734Timothy J Ziemlewicz · University Of Wisconsin-Madison · R01 · FY2023 · CA
Therapeutic targets in African-American youth with type 2 diabetes
$553,728Stephanie Therese Chung · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Metabolic Markers and Predictors of Childhood Obesity
$553,621Sonia Caprio · Yale University · R01 · FY2024 · HD
HIV Infection in Drug Users in Two International Sites
$553,592Sherwood L Gorbach · Tufts University Boston · R01 · FY2010 · DA
Fibroblast growth factor 1 prevents hyperlipidemia and atherosclerosis
$553,582Yi Tan · University Of Louisville · R01 · FY2022 · HL
The CNS Receptor For Asprosin
$553,467Atul Chopra · Case Western Reserve University · R01 · FY2025 · DK
The CNS Receptor For Asprosin
$553,467Atul Chopra · Case Western Reserve University · R01 · FY2023 · DK
Polymorphic ApoE at the crossroad of lipid metabolism and inflammation in atherosclerosis
$553,447David Y Hui · University Of Cincinnati · R01 · FY2024 · HL
Hepcidin therapy for iron overload and hematologic disorders
$553,380Stefano Rivella · Weill Medical Coll Of Cornell Univ · R01 · FY2013 · DK
Morning Meal-Associated Priming of the Liver
$553,374Alan D Cherrington · Vanderbilt University · R01 · FY2024 · DK
Hepatic Gene Transfer for Treatment of Hemophilias A & B
$553,368Mark A Kay · Stanford University · R01 · FY2017 · HL
Molecular Evolution Strategies to Derive New Recombinant AAV Vectors
$553,305Mark A Kay · Stanford University · R01 · FY2012 · HL
Hepcidin therapy for iron overload and hematologic disorders
$553,241Stefano Rivella · Weill Medical Coll Of Cornell Univ · R01 · FY2014 · DK
The STIRR Intervention for Dually Diagnosed Clients
$553,218Stanley D Rosenberg · Dartmouth College · R01 · FY2008 · MH
Novel mechanism based treatment to improve tissue injury in alcoholic hepatitis
$553,183Srinivasan Dasarathy · Cleveland Clinic Lerner Com-Cwru · R01 · FY2024 · AA
Influence of Heme on Hepatic Cytochrome P450 Turnover
$553,074Maria Almira Correia · University Of California, San Francisco · R01 · FY2014 · DK